Skip to content

Category: Press & Media

Proposed FDA Regulatory Flexibilities Permit Primary Diagnosis with Inspirata’s Dynamyx Digital Pathology Solution

Proposed FDA Regulatory Flexibilities Permit Primary Diagnosis with Inspirata’s Dynamyx Digital Pathology Solution

Regulatory flexibilities issued by the FDA may enable Inspirata’s digital pathology solution, Dynamyx, to be used for primary diagnosis in…

Sign up to receive Press & Media updates

Inspirata Digital Pathology Patent

Inspirata Announces Issuance of New U.S. Patent for its Digital Pathology System

Tampa, Florida, January 7, 2021 / GlobeNewswire – Cancer informatics and digital pathology provider Inspirata announced today that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent
Read More
Stephen Keresztes Vice President and Head of Oncology Informatics

Experienced Healthcare Leader Stephen Keresztes, MD, MBA Joins Inspirata as Head of Oncology Informatics

  Tampa, Florida, December 3, 2020 / GlobeNewswire – Inspirata announced today the appointment of Dr. Stephen Keresztes to the company’s leadership team. Effective December 1st, 2020, Dr. Keresztes serves
Read More
Inspirata & Smart Reporting

Inspirata and Smart Reporting Announce New Technical Partnership and Integration at Pathology Visions 2020

The new technical partnership between Inspirata and Smart Reporting endeavors to add structured reporting to case management within the Dynamyx Digital Pathology software suite.     Tampa, FL / Munich,
Read More

Inspirata and Flagship Biosciences Announce New Technical Partnership and Integration at Pathology Visions 2020

The new technical partnership between Inspirata and Flagship Biosciences provides clinicians with a seamless, fully automated AI send-out solution, offering significant advantages over standard material transfers.     Tampa, FL
Read More
Inspirata & Carebox

Inspirata Partners with Carebox to Deliver Powerful, Automated, Real-Time Clinical Trial Matching to Oncologists

Leveraging its clinically optimized data integration, NLP and AI technologies, Inspirata will extract key clinical data from pathology reports and the EHR system to construct patient-tailored clinical and genomic criteria.
Read More
Inspirata & National Cancer Institute NCI

National Cancer Institute (NCI) Extends Long-Standing Partnership with Inspirata

Inspirata’s growing portfolio of Cancer Case Finding and Registry Automation software solutions will be licensed to use within the SEER program for 14 central registries and over 300 hospitals and
Read More